Alzinova AB (FRA:78D) 12-1 Month Momentum %: -4.83% (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:78D Alzinova AB FRA:78D
32 GF Score
Price €0.02
View Full Analysis

What is Alzinova AB 12-1 Month Momentum %?

Alzinova AB FRA:78D -9.09% 32 12-1 Month Momentum % is -4.83% as of Sep. 21, 2026. GuruFocus rates FRA:78D with a GF Score™ of 32/100. Among 1,350 Biotechnology companies, Alzinova AB ranks worse than 50.89% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-21), Alzinova AB's 12-1 Month Momentum % is -4.83%.

The industry rank for Alzinova AB's 12-1 Month Momentum % or its related term are showing as below:

FRA:78D's 12-1 Month Momentum % is ranked worse than
50.89% of 1350 companies
in the Biotechnology industry
Industry Median: -20.6 vs FRA:78D: -4.83

Alzinova AB  (FRA:78D) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Alzinova AB 12-1 Month Momentum % Related Terms

FRA:78D vs VRTX, REGN, MRNA: 12-1 Month Momentum % Comparison

For the Biotechnology subindustry, Alzinova AB's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alzinova AB 12-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzinova AB's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Alzinova AB's 12-1 Month Momentum % falls into.


FRA:78D
32GF Score
Alzinova AB FRA:78D
12-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzinova AB  (FRA:78D) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of -4.83% mean?
Alzinova AB (FRA:78D) has a 12-1 Month Momentum % of -4.83% as of Sep. 21, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Alzinova AB and its competitors. According to the industry distribution chart, Alzinova AB ranks #687 out of 1350 companies in the Biotechnology industry, placing it in the top 50.9%.
Is Alzinova AB's 12-1 Month Momentum % too high?
Alzinova AB's current 12-1 Month Momentum % is -4.83%. Based on the distribution chart, Alzinova AB ranks #687 out of 1350 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alzinova AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alzinova AB's 12-1 Month Momentum % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alzinova AB ranks #687 out of 1350 companies for 12-1 Month Momentum %. This places Alzinova AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Biotechnology company?
A good 12-1 Month Momentum % depends on the Biotechnology industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Alzinova AB and its competitors. Alzinova AB's current 12-1 Month Momentum % is -4.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzinova AB stock overvalued right now?
Alzinova AB (FRA:78D) has a current 12-1 Month Momentum % of -4.83%. The current 12-1 Month Momentum % is -4.83%. Alzinova AB's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Alzinova AB (FRA:78D), the current 12-1 Month Momentum % is -4.83% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzinova AB Business Description

Other Exchanges ALZ:Sweden78D:Germany
Address Entreprenorsstraket 10, Molndal, SWE, 431 53
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is developing ALZ-101, an oligomer-specific therapeutic vaccine currently advancing toward Phase 2 clinical development, and ALZ-201, a monoclonal antibody targeting toxic amyloid-beta (AB) oligomers, which is in preclinical development. The company's proprietary ABCC peptide technology is focused on disease-modifying treatments for Alzheimer's disease.
32GF Score

Get the complete analysis for FRA:78D

12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price